Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma

BMC Clinical Pathology

Volumn 6, Issue , 2006, Pages

  Khoury, Thaer ^a   Tan, Dongfeng ^b   Wang, Jianmin ^a   Intengan, Marilyn ^a   Yang, Jun ^c   Alrawi, Sadir ^a   Yan, Peisha ^b   Byrd, James C ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; MUCIN 1; PROGESTERONE RECEPTOR; PROTEIN P16; TUMOR MARKER; VIMENTIN;

APICAL MEMBRANE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; MUCINOUS CARCINOMA; PROTEIN EXPRESSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA;

EID: 33644541783     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-6-1     Document Type: Article

References (39)

1. Berek JS, Hacker NV: cervical cancer, and uterine cancer. In Practical Gynecologic Oncology Volume 354. 3rd edition. Edited by: Lippincott Williams, Wilkins. Philadelphia; 2000:421.
2. Hoskins WJ, Perez CA, Young RC: uterine cervix, and corpus: epithelial tumors. In Principles and Practice of Gynecologic Oncology Volume 763. 4th edition. Edited by: Lippincott JB. Philadelphia; 2005:843.
3. Kamoi S, AlJuboury MI, Akin M, Silverberg SG: Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: Another viewpoint. Int J Gyn Pathol 2002, 21:217-223.
4. McCluggage WG, Sumathi VP, McBride HA, Patterson A: A panel of immunohistochemical stains including carcinoembryonic antigen, vimentin, and estrogen receptor aids in the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002, 21:11-5.
5. Zaino RJ: The fruits of our labors: distinguishing endometrial from endocervical adenocarcinoma. Int J Gynecol Pathol 2002, 21:1-3.
6. Wahlstrom T, Lindgren J, Korhonen M, Seppala M: Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological specimens. Lancet 1979, 2:1159-61.
7. Cohen C, Shulman G, Budgeon L: Endocervical and endometrial adenocarcinoma: an immunoperoxidase and immunohistochemical study. Am J Surg Pathol 1982, 6:151-7.
8. Dabbs DJ, Geisinger KR, Norris HT: Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986, 10:568-76.
9. Dabbs D, Geisinger K: Selective applications of immunohistochemistry in gynecological neoplasms. Pathol Annu 1993, 28(1):329-53.
10. Dabbs D, Sturtz K, Zaino R: The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996, 27:172-7.
11. Toda T, Sadi AM, Egawa H, Atari E, Qureshi B, Nagai Y: Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium. Histopathology 1998, 32:257-63.
12. Staebler A, Sherman ME, Ronnett BM: Hormone receptor immunohistochemistry (IHC) and HPV in situ hybridization (ISH) are useful for distinguishing between primary endocervical and endometrial adenocarcinomas. Mod Pathol 2001, 14:856.
13. Castrillon D, Lee K, Nucci M: Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 2002, 21:4-10.
14. Maes G, Fleuren GJ, Bara J, Nap M: The distinction of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas. Int J Gynecol Pathol 1988, 7:112-22.
15. Kudo R, Sasano H, Koizumi M, Orenstein JM, Silverberg SG: Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 1990, 9:325-36.
16. McCluggage WG, Jenkins D: p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003, 22(3):231-235.
17. Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM: Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004, 28(2):160-167.
18. Dekker J, Rossen JW, Buller HA: The MUC family: an obituary. Trends Biochem Sci 2002, 27:126-131.
19. Oniaux N, Escande F, Porchet N: Structural organization and classification of the human mucin genes. Front Biosci 2001, 6:1192-1206.
20. Brayman M, Thathiah A, Carson DD: MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2004, 2:4.
21. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R: Expression ofMUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod Pathol 2004, 17:180-8.
22. Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L, Anastasiadis P: Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology 2002, 40:92-100.
23. Acosta AA, Elberger L, Borghi M: Endometrial dating and determination of the window of implantation in healthy fertile women. Fertility & Sterility 2000, 73:788-98.
24. Carson DD, DeSouza MM, Kardon R, Zhao X, Lagow E, Julian J: Mucin expression and function in the female reproductive tract. Human Reproduction Update 1998, 4:459-464.
25. Meseguer M, Pellicer A, Simon C: MUC1 and endometrial receptivity. Molecular Human Reproduction 1998, 4:1089-98.
26. Meseguer M, Aplin JD: Human endometrial mucin MUC1 is upregulated by progesterone and down-regulated in vitro by the human blastocyst. Biology of Reproduction 2001, 64:590-601.
27. Gipson IK: Mucin genes expressed by human female reproductive tractepithelia. Biology of Reproduction 1997, 56:999-1011.
28. Hewetson A, Chilton BS: Molecular cloning and hormone-dependent expression of rabbit Muc1 in the cervix and uterus. Biol Reprod 1997, 57:468-77.
29. Price MR, Rye PD, Petrakou E: Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumor Biol 1998, 19(Suppl 1):1-20.
30. Remmele W, Schicketanz K-H: Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 1993, 189:862-866.
31. Keating JT, Cviko A, Reithdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP: Ki-67, cyclin E and p16 (INK 4) are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001, 25:894-891.
32. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M: Overexpression of p16 (INK 4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001, 92:276-284.
33. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M: p16 ink 4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. J Pathol 2001, 195:2A.
34. Murphy N, Bermingham N, Ring M: Immunocytochemical analysis of p16 protein in cervical cancer and cervical intraepithelial neoplasia. J Pathol 2001, 195:2A.
35. Ruas M, Peters G: The p16 INK 4a/CDKN2A tumor suppressor and its relatives. Biochem Biophys Acta 1998, 1378:115-117.
36. Cameron RI, Maxwell P, Jenkins D, MCluggage WG: Immunohistochemical staining with MIB1, bcl-2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002, 41:313-21.
37. Semczuk A, Stenzel A, Baranowski W, Rozynska K, Cybulski M, Kostuch M, Jakowicki J, Wojcierowski J: Detection of human papillomavirus types 16 and 18 in human neoplastic endometrium: lack of correlation with established prognostic factors. Oncol Reports 2000, 7:905-910.
38. Brewster WR, Monk BJ, Burger RA, Bergen S, Wilczynski SP: Does human papillomavirus have a role in cancers of the uterine corpus? Gynecol Oncol 1999, 75:51-54.
39. O'Leary JJ, Landers RJ, Crowley M, Healy I, O'Donovan M, Healy V, Kealy WF, Hogan J, Doyle CT: Human papillomavirus and mixed epithelial tumorsof the endometrium. Hum Pathol 1998, 29:383-389.